ArticleThe Journal of clinical investigation2026
Targeting KIT prevents brain arteriovenous malformations driven by ALK1-deficient angiogenic endothelial cells.
Elise Drapé et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it